Orphan : Actualité Orphan en direct - P1 | Bourse Reflex
Accueil > Tags > Orphan

  • Toutes les actualités en rapport avec « Orphan »

02/05 07:30 Orphan - ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AND 6 MAY IN MONTPELLIER

26/04 18:00 Orphan - THERANEXUS ANNOUNCES ITS 2017 ANNUAL RESULTS AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS CLINICAL TRIALS

23/04 07:30 Orphan - THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)

19/04 18:00 Orphan - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

28/09 07:30 Orphan - Theranexus files its registration document as part of its planned Initial Public Offering (IPO) on the Euronext Growth market in Paris

28/02 17:45 Orphan - Genticel becomes Genkyotex: Genticel's General Meeting approves the strategic combination with GenKyoTex SA

30/01 18:00 Orphan - BUSINESS UPDATE - FOURTH QUARTER 2016

22/12 13:00 Orphan - Genticel and Genkyotex Announce Intention to Enter into Strategic Combination

21/09 17:00 Orphan - PRE-IPO : Launch of AlzProtect's fundraising

29/07 09:00 Orphan - Cancer Prevention Pharmaceuticals Receives Positive Scientific Advice From EMA for CPP-1X Phase III TRIAL in FAP

25/07 12:30 Orphan - Raptor Pharmaceutical Meets Primary Endpoint in Its Phase 3 Clinical Trial of DR Cysteamine for Nephropathic Cystinosis

06/07 12:35 Orphan - Raptor Pharmaceutical Receives Notices of Allowance for Two Key Patent Applications Protecting Its Cysteamine Portfolio

09/06 05:00 Orphan - Edison Pharmaceuticals annonce l'octroi de la désignation de medicament orphelin EPI-743 de la FDA

20/05 16:10 Orphan - Apricus Biosciences Will Request Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Switzerland, Based on Guidance From Swiss Regulatory Authorities

19/05 14:45 Orphan - Apricus Biosciences Receives Guidance From Swiss Regulatory Authorities Regarding Filing for Market Authorization of Vitaros(R) for Erectile Dysfunction in Switzerland

29/04 09:30 Orphan - Merck Serono: une nouvelle présentation de Cyanokit(R) approuvée par la FDA aux Etats-Unis

13/04 19:45 Orphan - Apricus Biosciences Files for Orphan Drug Designation for RayVa(TM)

22/03 14:55 Orphan - Apricus Biosciences Announces Poster Presentations on Progress of PrevOnco(TM) in Combination With NexACT(R) Technology at the American Association for Cancer Research 2011 Annual Meeting

28/02 11:08 Orphan - Les maladies orphelines profitent aux biotechs (Dexia AM)

24/02 09:30 Orphan - Orphan Europe recordati participera a la journee des maladies rares - << rareté mais egalité >>